Humana Wins Statewide Illinois Medicaid Contract, Set to Go Live Jan 2027
HUM has more than doubled off its 52-week low of $163.11.
Summary
Humana has been awarded a statewide Illinois Healthchoice Medicaid contract, a significant win that expands its market presence. This new contract is set to go live in January 2027, promising a substantial new revenue stream and membership growth for the company. This follows other recent positive developments, including strong Medicare Advantage growth expectations and an expanded partnership with Mark Cuban Cost Plus Drug Company.
At the time of this announcement, HUM was trading at $369.49 on NYSE in the Life Sciences sector, with a market capitalization of approximately $44.4B. The 52-week trading range was $163.11 to $380.86. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.